Get started
Author

Shalton M. Mwaringa

Observed names: Mwaringa, Shalton, S Mwaringa, Shalton Lwambi Mwaringa, Shalton M Mwaringa, Shalton Mwaringa
ORCID: 0009-0003-5944-6402
Observed ORCID: 0009-0003-5944-6402
OpenAlex ID: A5078570201
Childhood mortality during and after acute illness in Africa and south Asia: a prospective cohort study
2022 · Abdoulaye Hama Diallo, Abu Sadat Mohammad Sayeem Bin Shahid, et al. · The Lancet Global Health · 123
HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study
2014 · Amin S Hassan, Helen M Nabwera, et al. · AIDS Research and Therapy · 101
PDF
Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial
2018 · Cissy Kityo, Alexander J. Szubert, et al. · PLoS Medicine · 38
PDF
Incidence and predictors of attrition from antiretroviral care among adults in a rural HIV clinic in Coastal Kenya: a retrospective cohort study
2015 · Amin S Hassan, Shalton M Mwaringa, et al. · BMC Public Health · 38
PDF
Outcomes of prevention of mother to child transmission of the human immunodeficiency virus-1 in rural Kenya—a cohort study
2015 · Eunice Wambui Nduati, Amin Shaban Hassan, et al. · BMC Public Health · 36
PDF
Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial
2018 · Abraham Siika, Leanne McCabe, et al. · Clinical Infectious Diseases · 33
PDF
Control of Viremia Enables Acquisition of Resting Memory B Cells with Age and Normalization of Activated B Cell Phenotypes in HIV-Infected Children
2015 · Daniel M Muema, Gladys N Macharia, et al. · The Journal of Immunology · 32
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial
2018 · Jane Mallewa, Alexander J Szubert, et al. · The Lancet HIV · 30
PDF
Low Prevalence of Transmitted HIV Type 1 Drug Resistance Among Antiretroviral-Naive Adults in a Rural HIV Clinic in Kenya
2012 · Amin S. Hassan, Shalton M. Mwaringa, et al. · AIDS Research and Human Retroviruses · 26
Characterising paediatric mortality during and after acute illness in Sub-Saharan Africa and South Asia: a secondary analysis of the CHAIN cohort using a machine learning approach
2023 · Abdoulaye Hama Diallo, Abu Sadat Mohammad Sayeem Bin Shahid, et al. · EClinicalMedicine · 22
Dosing of Ceftriaxone and Metronidazole for Children With Severe Acute Malnutrition
2018 · Joseph F. Standing, Martin O. Ongas, et al. · Clinical Pharmacology & Therapeutics · 22
PDF
Presence, persistence and effects of pre-treatment HIV-1 drug resistance variants detected using next generation sequencing: A Retrospective longitudinal study from rural coastal Kenya
2019 · Amin S. Hassan, David F. Bibby, et al. · PLoS ONE · 21
PDF
Infant-level and child-level predictors of mortality in low-resource settings: the WHO Child Mortality Risk Stratification Multi-Country Pooled Cohort
2025 · Tahmeed Ahmed, Waseem Ali, et al. · The Lancet Global Health · 19
Childhood growth during recovery from acute illness in Africa and South Asia: a secondary analysis of the childhood acute illness and nutrition (CHAIN) prospective cohort
2024 · Celine Bourdon, Abdoulaye Hama Diallo, et al. · EClinicalMedicine · 13
PDF
Genetic variation in VAC14 is associated with bacteremia secondary to diverse pathogens in African children
2018 · James J. Gilchrist, Alexander J. Mentzer, et al. · Proceedings of the National Academy of Sciences · 13
Toll-Like Receptor-Induced Immune Responses During Early Childhood and Their Associations With Clinical Outcomes Following Acute Illness Among Infants in Sub-Saharan Africa
2022 · Luke S. Uebelhoer, Agnes Gwela, et al. · Frontiers in Immunology · 8
PDF
Hospital readmission following acute illness among children 2–23 months old in sub-Saharan Africa and South Asia: a secondary analysis of CHAIN cohort
2024 · Abdoulaye Hama Diallo, Abu Sadat Mohammad Sayeem Bin Shahid, et al. · EClinicalMedicine · 7
Risk of pneumococcal bacteremia in Kenyan children with glucose-6-phosphate dehydrogenase deficiency
2020 · James J. Gilchrist, Sophie Uyoga, et al. · BMC Medicine · 7
PDF
Catastrophic expenditure associated with childhood hospitalisation for acute illness in Kenya and Uganda: a cross-sectional study
2025 · Julie Jemutai, Rebecca Gathoni Njuguna, et al. · BMJ Public Health · 5
PDF
Aflatoxin exposure and mortality in acutely ill children: results from the CHAIN network cohort
2025 · Lei Xia, Hang Wu, et al. · BMJ Global Health · 4
PDF
Inflammation impairs post-hospital discharge growth among children hospitalised with acute illness in sub-Saharan Africa and south Asia
2025 · James M. Njunge, Evans O. Mudibo, et al. · Nature Communications · 3
PDF
12-week raltegravir-intensified quadruple therapy versus triple first-line ART reduces viral load more rapidly but does not reduce mortality in severely immunosuppressed African HIV-infected adults and older children: the REALITY trial
2016 · C. Kityo, Abraham Siika, et al. · UCL Discovery (University College London) · 2
ALARUM: Active One Health surveillance in LMICs to monitor and predict Antimicrobial Resistance Using Metagenomics – a cross-sectional study protocol
2026 · Marianne A B van der Sande, Daniel Valia, et al. · BMJ Open · 1
PDF
Antimicrobial Usage Among Acutely Ill Hospitalized Children Aged 2‒23 Months in Sub-Saharan Africa and South Asia
2025 · Caroline Tigoi, Celine Bourdon, et al. · Open Forum Infectious Diseases · 1
PDF
Enteropathogen detection and early mortality among people with advanced HIV disease in sub-Saharan Africa
2025 · Helen Jones, Victor Riitho, et al. · Research Square
PDF
Works count: 34
Citation count: 605
H-index: 13
I10-index: 15
Year
Topic
Type